financetom
Business
financetom
/
Business
/
COVID surge has no impact on our expansion plans in India, says Accor COO
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
COVID surge has no impact on our expansion plans in India, says Accor COO
Apr 6, 2021 9:31 AM

Hospitality has been one of the worst hit sectors by the coronavirus pandemic. After facing existential challenges in the last one year, the industry expects 2021 to ring in better times.

French multinational hospitality major Accor is hopeful that worldwide rollout of COVID-19 vaccines will lead to renewed trust in travel, in fact the company which has over 50 properties in India currently, plans to open 30 new hotels here over the next five years.

In an exclusive interview to CNBC-TV18 Managing Editor Shereen Bhan, Marc Descrozaille, COO of India, Middle East & Africa at Accor said India is a key market for the company and the recent spike in COVID cases has not impacted their expansion plans.

"We are investing in the hotel sector not for the short run but for the longer run. The recent spike in COVID cases has not at all impacted our expansion plans in India, in fact we are planning to have 4 hotels open this year. However when it comes to clients coming to our hotels, we are seeing a 10 percent drop compared to the previous week and this is the impact that we are noticing throughout the country. "

He expects the staycation segment to be the focus and a driver of revenue.

"The saving grace for us has been the staycation segment - which is very much the people residing in each of the countries actually using their spare time to go and stay there, use the beaches, use resorts, use the malls and use Accor hotels. So that has been the market that we got during the pandemic and is the focus at the moment."

Watch video for more.

(Edited by : Aditi Gautam)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
General Motors Q1 US Vehicle Sales Fall 1.5%, Retail Sales Rise 6%
General Motors Q1 US Vehicle Sales Fall 1.5%, Retail Sales Rise 6%
Apr 2, 2024
12:30 PM EDT, 04/02/2024 (MT Newswires) -- General Motors ( GM ) said Tuesday that it sold 594,233 vehicles in the US in Q1, down 1.5% from a year earlier on lower fleet deliveries. The company and its dealers increased retail sales by 6%, the automaker said. Price: 44.97, Change: -0.44, Percent Change: -0.96 ...
--Endeavor Group's Stock Trading Halted, Pending Material News Release
--Endeavor Group's Stock Trading Halted, Pending Material News Release
Apr 2, 2024
12:25 PM EDT, 04/02/2024 (MT Newswires) -- Price: 25.19, Change: -0.10, Percent Change: -0.40 ...
PC, console growth to lag pre-pandemic levels as gamers clock in fewer hours, report says
PC, console growth to lag pre-pandemic levels as gamers clock in fewer hours, report says
Apr 2, 2024
(Reuters) - Personal computing and console gaming revenue growth is expected to remain below pre-pandemic levels through 2026 as gamers record fewer hours of playtime, according to research firm Newzoo. The market is expected to grow 2.7% from 2023-end to 2026, below the 7.2% growth rate from 2015 to 2021, according to the report. Gamers have been recording fewer hours...
Vivek Ramaswamy-Founded Roivant's Anti-Inflammatory Drug Aces Mid-Stage Study
Vivek Ramaswamy-Founded Roivant's Anti-Inflammatory Drug Aces Mid-Stage Study
Apr 2, 2024
Tuesday, Roivant Sciences ( ROIV ) and Priovant Therapeutics announced results from the Phase 2 study (NEPTUNE) evaluating brepocitinib in non-anterior non-infectious uveitis (NIU).  Roivant Sciences ( ROIV ) was founded by former Republican Party presidential candidate Vivek Ramaswamy. NIU is a group of disorders characterized by intraocular inflammation at different levels of the eye. At week 24, 29% (5/17) of subjects in...
Copyright 2023-2025 - www.financetom.com All Rights Reserved